Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 8.62B | 8.87B | 7.58B | 9.79B | 13.66B |
Gross Profit | 2.40B | 2.40B | 2.03B | 3.98B | 7.48B |
EBITDA | -173.21M | -714.33M | -134.89M | -1.49B | -2.11B |
Net Income | -203.71M | -531.55M | -338.83M | -917.33M | -1.23B |
Balance Sheet | |||||
Total Assets | 6.53B | 6.83B | 6.76B | 6.18B | 39.84B |
Cash, Cash Equivalents and Short-Term Investments | 640.72M | 1.05B | 508.86M | 351.04M | 11.64B |
Total Debt | 882.39M | 922.33M | 843.11M | 895.35M | 15.91B |
Total Liabilities | 3.42B | 3.92B | 3.84B | 3.36B | 25.76B |
Stockholders Equity | 1.74B | 1.65B | 2.01B | 2.13B | 4.02B |
Cash Flow | |||||
Free Cash Flow | -371.58M | -200.84M | -25.23M | 708.21M | 7.22B |
Operating Cash Flow | -324.46M | -75.08M | 9.28M | 826.86M | 7.41B |
Investing Cash Flow | -58.24M | -180.00M | 30.65M | 432.94M | -357.17M |
Financing Cash Flow | -32.86M | 784.60M | -111.24M | -1.31B | -6.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ¥19.04B | 7.44 | 3.81% | 0.79% | 60.97% | ||
71 Outperform | ¥86.57B | 13.20 | 2.37% | 2.81% | -8.76% | ||
65 Neutral | ¥2.41B | 8.09 | 4.08% | -4.12% | 2.97% | ||
64 Neutral | ¥2.31B | 11.35 | 1.32% | -2.00% | ― | ||
57 Neutral | £2.60B | 5.06 | -9.48% | 48.68% | 5.72% | -4.86% | |
52 Neutral | ¥4.17B | ― | ― | -2.81% | 61.68% |